With drugs going off patent over the next three years valued at around a whopping Rs 3,20,000 crore (US$ 80 billion) and also increased penetration of generics in the global market, Indian pharmaceutical industry sees a great opportunity and various stakeholders are gearing up to obtain a share in the pie that appears to be lucrative.

More...